Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Western Ontario

$20,000.00

L2M - NSERC Development of a tool for diagnosis of diabetic complications

FY 2022-23

Summary
The researchers here propose developing a software application that can leverage artificial intelligence and machine learning to diagnose a disease using inputted biomarker levels. The software application would first be customized for disease causing blindness in diabetes, also known as diabetic retinopathy (DR). Dr. Chakrabarti and his team, with the assistance of WORLDiscoveries, have filed for a patent currently at the PCT stage (PCT/CA2021/050924). The current technology uses expression levels of a set of genes to diagnose if the patient has developed DR and what stage they are at. Patient differences exist, and the team is currently testing 500 additional patients to validate the biomarker technology (patent application filed). The data from this study will be fed into the current software application that has been planned to be developed. This will allow with much accuracy, family physicians and ophthalmologists to enter the data from the laboratory test into this system to accurately diagnose the progression of the disease.Furthermore, the application will also be developed for other disease diagnoses that are biomarker level dependent. The current software application algorithm will be tailored to disease-specific use. The goal will be to partner with biomarker testing panels and centres to integrate the existing software into their workflow. The current technology as a software application would the first of its kind to be used in the rapidly growing field of using biomarkers to identify and validate diseases.
Program
Idea to Innovation
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
576601-2022
Name nom
Chakrabarti, Subrata SUBR
Department département
Schulich School of Medicine & Dentistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Installment
inst:1
Partie
1
Nb partie
1
Application title
L2M - NSERC Development of a tool for diagnosis of diabetic complications
Application summary
The researchers here propose developing a software application that can leverage artificial intelligence and machine learning to diagnose a disease using inputted biomarker levels. The software application would first be customized for disease causing blindness in diabetes, also known as diabetic retinopathy (DR). Dr. Chakrabarti and his team, with the assistance of WORLDiscoveries, have filed for a patent currently at the PCT stage (PCT/CA2021/050924). The current technology uses expression levels of a set of genes to diagnose if the patient has developed DR and what stage they are at. Patient differences exist, and the team is currently testing 500 additional patients to validate the biomarker technology (patent application filed). The data from this study will be fed into the current software application that has been planned to be developed. This will allow with much accuracy, family physicians and ophthalmologists to enter the data from the laboratory test into this system to accurately diagnose the progression of the disease.Furthermore, the application will also be developed for other disease diagnoses that are biomarker level dependent. The current software application algorithm will be tailored to disease-specific use. The goal will be to partner with biomarker testing panels and centres to integrate the existing software into their workflow. The current technology as a software application would the first of its kind to be used in the rapidly growing field of using biomarkers to identify and validate diseases.
University of Western Ontario - $20,000 Grant (2022-2… | Canada Spends